Product Information
TIROSINT 137 MCG CAPSULE is a brand product labeled by IBSA Pharma Inc., priced at $4.4923 per EA under NDC 71858004504. Its NADAC has been published 296 times since Feb 6, 2019.
The High Outlier badge above means this manufacturer's average price in the levothyroxine sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
137 ug/1
Manufacturer
IBSA Pharma Inc.NDC
71858004504
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
7/1/2024
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021924On Market Since
12/1/2018
Pharmacological Classes
Price Statistics
The NADAC for TIROSINT 137 MCG CAPSULE has been published 296 times since Feb 6, 2019, and over the history we have for it it has risen 10.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4923 per EA |
|---|---|
| All-time high | $4.4923 (Oct 2, 2024) |
| All-time low | $4.0754 (Feb 6, 2019) |
| Median price | $4.2753 |
| Average price | $4.2699 |
| Largest weekly change | +4.0% (Dec 25, 2019) |
| Weeks tracked | 296 |
| Tracking since | Feb 6, 2019 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TIROSINT 137 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIROSINT 137 MCG CAPSULE, manufactured by IBSA Pharma Inc., is $4.4923 per EA (NDC 71858004504), effective Oct 2, 2024.
How has the price of TIROSINT 137 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIROSINT 137 MCG CAPSULE has risen 10.2%. It has been tracked across 296 weekly CMS publications since Feb 6, 2019.
What are the highest and lowest recorded NADAC prices for TIROSINT 137 MCG CAPSULE?
Since Feb 6, 2019, the NADAC for TIROSINT 137 MCG CAPSULE has ranged from a low of $4.0754 (Feb 6, 2019) to a high of $4.4923 (Oct 2, 2024), with a median of $4.2753 per EA.
Are there cheaper alternatives to TIROSINT 137 MCG CAPSULE?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEVOTHYROXINE 137 MCG TABLET, is $0.0630 per EA — about 99% below TIROSINT 137 MCG CAPSULE.
Who manufactures TIROSINT 137 MCG CAPSULE?
TIROSINT 137 MCG CAPSULE (NDC 71858004504) is labeled by IBSA Pharma Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification